|
ZNF302 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.414600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.196800E-04 |
| Normal-vs-Stage2 |
8.279500E-02 |
| Normal-vs-Stage3 |
2.434300E-02 |
| Normal-vs-Stage4 |
2.126600E-01 |
| Stage1-vs-Stage2 |
8.446000E-01 |
| Stage1-vs-Stage3 |
9.042600E-01 |
| Stage1-vs-Stage4 |
1.359020E-01 |
| Stage2-vs-Stage3 |
7.940800E-01 |
| Stage2-vs-Stage4 |
3.222600E-01 |
| Stage3-vs-Stage4 |
2.943600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.179800E-03 |
| Normal-vs-AfricanAmerican |
2.011900E-02 |
| Normal-vs-Asian |
1.752020E-01 |
| Caucasian-vs-AfricanAmerican |
5.323200E-01 |
| Caucasian-vs-Asian |
2.598000E-01 |
| AfricanAmerican-vs-Asian |
3.045400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.027800E-02 |
| Normal-vs-Female |
4.12730000000083E-05 |
| Male-vs-Female |
2.047600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.979000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.153800E-04 |
| Normal-vs-Age(61-80Yrs) |
5.982400E-03 |
| Normal-vs-Age(81-100Yrs) |
4.932200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.249800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.938400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.483400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.575400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.861600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.844400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.95570000000234E-06 |
| Normal-vs-Grade 2 |
3.66640000004637E-06 |
| Normal-vs-Grade 3 |
2.479800E-02 |
| Normal-vs-Grade 4 |
1.933620E-01 |
| Grade 1-vs-Grade 2 |
3.183200E-01 |
| Grade 1-vs-Grade 3 |
4.049900E-02 |
| Grade 1-vs-Grade 4 |
1.605450E-04 |
| Grade 2-vs-Grade 3 |
2.069800E-02 |
| Grade 2-vs-Grade 4 |
9.22480000054016E-07 |
| Grade 3-vs-Grade 4 |
2.681400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.8715000094669E-09 |
| Normal-vs-ccB subtype |
9.132600E-01 |
| ccA subtype-vs-ccB subtype |
1.34530000028832E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.581080E-03 |
| Normal-vs-N1 |
9.796400E-01 |
| N0-vs-N1 |
3.052800E-01 |
|
|
